26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
On June 18, 2019, Governor Ned Lamont signed into law a new bill imposing significant changes to sex...
Read More >
When an employer permits its employees to participate in a bonus program offered by the employer’s ...
Read More >
Can an employer provide health care coverage for its employees by simply setting aside cash for them...
Read More >
Welcome to the newest addition to the Compliance Podcast Network, Compliance and Coronavirus. In thi...
Read More >
In a recent Chief Counsel General Advice Memorandum (“Memo”), the IRS provides a helpful reminder ...
Read More >
In 2016, Pennsylvania enacted its “Medical Marijuana Act” (MMA), which permits individuals sufferi...
Read More >